Immunosuppression after pediatric liver transplant: The parents’ perspective

Abstract

AbstractBackgroundFor children with liver transplants (LT), achieving an “ideal outcome” is a balancing act: too little immunosuppression begets graft injury; too much begets systemic complications. We aimed to delineate the parental perspective on this tightrope.MethodsParents of children with LT completed an internet‐based survey about their child's immunosuppression.ResultsChildren of respondents (n = 82) were a median 4 years from primary LT (range 0–22); 73% were on immunosuppression monotherapy. Parents’ top concerns were related to immunosuppression complications; 46% were more concerned about immunosuppression complications than rejection; only 17% were more concerned about rejection than immunosuppression complications. Among parents of children on immunosuppression monotherapy, 29% still worried more about immunosuppression complications than rejection, 48% expressed equal concern for both. Time since LT (0‐4 vs. >4 years) was not associated with concern level for rejection or immunosuppression complications. Caregivers were significantly more certain that their child's immunosuppression regimen was correct to prevent rejection than to mitigate complications (p < .005).ConclusionCaregivers of children with LTs reported higher levels of concern and uncertainty about immunosuppression complications than rejection risk. Understanding parent and patient perspectives on IS, and incorporating them into immunosuppression counseling and decision‐making, is critical to achieving truly “ideal” long‐term outcomes.